Skip to main content
Equibles

WELCURE · WELCURE DRUGS & PHARMACEUTICAL · Financials

Use WELCURE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WELCURE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.19 INR +0.00 (+0.00%) At close · Nov 13
Rebalance outlook locked
Market Cap
234.83M INR
Shares
1.24B
Volume · Nov 13 2.3M Avg daily vol (3M) 5.47M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
3.9B +1486.7%
FY2026 Revenue FY2025–FY2026
Net Income
-56.71M -361.3%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
13.08M +100.6%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2026 FY2025
INR 3.9B 245.5M
INR 192K 76K
INR 0 0
INR -56.71M 27.8M
INR 0 6.1M
INR -56.71M 21.7M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.